Nutriband Inc. (NTRB)
$6.65+9.92%Close
SELLCRISIS · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $81M
- Beta
- 1.93
- P/E (TTM)
- -11.68
- Short % float
- 2.91%
- Days to cover
- 1.0
- SI change
- -13.7%
- 1W
- -8.65%
- 1M
- +9.38%
- vs SPY 1W
- -9.81%
- vs SPY 1M
- +6.38%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 13
- VALUE
- 19
- GROWTH
- 4
- GARP
- 8
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC-65.4%
REV YoY-
ROE-109.0%
EPS YoY-
ROA-110.6%
GROSS33
OP-436
NET-430
[VALUATION]
P/E TTM-11.68
P/E FWD4.82
SECTOR PE20.47
INDUSTRY PE13.95
P/B15.24
P/FCF-
EV/EBITDA-11.45
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E3.65
ALTMAN Z-
CURR RATIO4.21
ND/EBITDA-
BETA1.93
Company news
FAQ
- What is LOPJLB’s current signal on NTRB?
- LOPJLB’s latest quantitative signal on Nutriband Inc. (NTRB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is NTRB in?
- Nutriband Inc. (NTRB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Nutriband Inc. (NTRB) do?
- Nutriband Inc. specializes in developing a diverse range of pharmaceutical products delivered via transdermal patches. The company's most advanced program centers on AVERSA fentanyl, an innovative fentanyl transdermal system engineered to prevent abuse. This extended-release patch provides healthcare professionals and patients with a continuous opioid therapy solution for the ongoing management…